SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more ...
GoodRx launched GoodRx Companion, a new $14.99-per-month subscription to lower everyday healthcare costs Provides access to free and low-cost generic medications, affordable online care, and savings ...
GoodRx is expanding access to the newly FDA-approved oral GLP-1 medication, Foundayoâ„¢ (orforglipron) Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRx GoodRx is ...